With IQVIA AI & machine learning, you can move with precision, speed and scale across every phase of your product’s lifecycle. And you can use these technologies right now, today. Read on and talk with our experts to learn how we're making it happen.
Learn MoreThe power of data at scale
Guided by our AI & machine learning approaches, we can work with you to make sense of vast amounts of data. You’ll uncover insights invisible to your competitors, enhancing your discovery of new therapies and transforming your business strategies.
We understand that you need to solve for tough challenges in clinical development, compliance and commercialization. That’s why we’re delivering practical AI & machine learning applications grounded in 50 years of deep expertise and innovation.
These industry-leading technologies are driven by the thinking of thousands of data scientists and accelerated on an analytics engine with an ever-expanding library of methodologies and algorithms.
And results are achievable today. You can realize significant improvements with our AI & machine learning powered solutions, optimizing promotional mix, targeting the highest potential HCPs, generating payer-ready evidence, and executing new models of patient engagement.
A mid-size pharma customer needed to increase the effectiveness of their multi-channel HCP promotion.
By applying machine learning techniques, IQVIA helped them:
By integrating machine learning with primary research and HCP prescriber data, IQVIA helped one client pioneer an innovative way to precisely segment HCPs based on their attitudes and behavior, and to prioritize HCPs based on prescriber value. This empowered the client to create brand communications leveraging the highest value personal and non-personal promotion approaches — tailored to each specific HCP.
One IQVIA client wanted to ensure its digital content was delivered with precision to the most relevant audience. We leveraged our vast data platform and proprietary machine learning to predict the relevance of certain health conditions. Media partners could then execute accurate, programmatic targeting to the most qualified customers in near real-time.
Using machine learning to analyze the medical claims of more than 150 million patients, IQVIA accelerates the time to diagnosis for patients with cancer and other rare diseases. By combining multiple models, we achieved 97% accuracy for HCV prediction.
AI & machine learning algorithms require the right data to be effective. We push the limits of seamless data integration, combining multiple types — like LRx data, EMR data, claims data and genomics data — making it possible to develop game-changing insights and competitive advantage on both a global and local scale.
Learn MoreIQVIA leverages AI & machine learning algorithms across 35+ analytics-based commercial offerings: